Published in Evid Based Complement Alternat Med on January 26, 2017
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report (2008) 19.25
Complementary and alternative medicine use among adults: United States, 2002. Adv Data (2004) 17.17
Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod (2012) 13.27
Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med (2005) 6.27
Alternative medicine--the risks of untested and unregulated remedies. N Engl J Med (1998) 4.63
Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol (2008) 4.60
Botanical medicines--the need for new regulations. N Engl J Med (2002) 4.04
Complementary and alternative medicine use in Australia: a national population-based survey. J Altern Complement Med (2007) 3.80
Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. Lancet Oncol (2013) 3.56
What is complementary medicine? BMJ (1999) 3.10
A systematic review of beliefs involved in the use of complementary and alternative medicine. J Health Psychol (2007) 2.86
Guidelines for the management of basal cell carcinoma. Br J Dermatol (2008) 2.57
Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med (2008) 2.08
Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol (1992) 1.94
Chemosurgery for skin cancer: fixed tissue and fresh tissue techniques. Arch Dermatol (1976) 1.56
Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. Am J Prev Med (2014) 1.55
A case of do-it-yourself Mohs' surgery using bloodroot obtained from the internet. Br J Dermatol (2007) 1.39
Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase. Cancer Res (2000) 1.33
Experimental rationale for treatment of high-risk human melanoma with zinc chloride fixative paste. Increased resistance to tumor challenge in murine melanoma model. Dermatol Surg (1998) 1.33
Cytotoxicity evaluation of 43 metal salts using murine fibroblasts and osteoblastic cells. J Biomed Mater Res (1998) 1.30
Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol (2005) 1.29
Escharotic and other botanical agents for the treatment of skin cancer: a review. J Am Acad Dermatol (2005) 1.27
Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med Sci Monit (2010) 1.24
Internet health resources and the cancer patient. Cancer Invest (2008) 1.23
Natural products and combinatorial chemistry: back to the future. Curr Opin Chem Biol (2004) 1.22
Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Arch Dermatol (2009) 1.22
Five-year results of Mohs' micrographic surgery for aggressive facial basal cell carcinoma in Sweden. Acta Derm Venereol (1999) 1.19
Quantitative assessment of the relative antineoplastic potential of the n-butanolic leaf extract of Annona muricata Linn. in normal and immortalized human cell lines. Asian Pac J Cancer Prev (2012) 1.17
The use of complementary alternative medicine (CAM) in 1 001 German adults: results of a population-based telephone survey. Gesundheitswesen (2008) 1.16
Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin Cancer Res (2000) 1.16
More people die from thin melanomas (⩽1 mm) than from thick melanomas (>4 mm) in Queensland, Australia. J Invest Dermatol (2014) 1.16
Oleandrin suppresses activation of nuclear transcription factor-kappa B and activator protein-1 and potentiates apoptosis induced by ceramide. Biochem Pharmacol (2003) 1.14
Implementing a research agenda for complementary and alternative medicine. Annu Rev Med (2004) 1.12
Self-treatment of a basal cell carcinoma with "black and yellow salve". J Am Acad Dermatol (2005) 1.11
Dimethyl sulfoxide: history, chemistry, and clinical utility in dermatology. J Clin Aesthet Dermatol (2012) 1.11
Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg (2000) 1.10
New hemostatic method using Mohs' paste for fatal genital bleeding in advanced cervical cancer. Gynecol Oncol Case Rep (2013) 1.09
An Internet misadventure: bloodroot salve toxicity. J Altern Complement Med (2010) 1.07
Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. BMJ (2013) 1.00
The pharmacology of dimethyl sulfoxide. Annu Rev Pharmacol (1972) 0.96
Rapid human melanoma cell death induced by sanguinarine through oxidative stress. Eur J Pharmacol (2013) 0.95
DNA-binding affinities and sequence selectivity of quaternary benzophenanthridine alkaloids sanguinarine, chelerythrine, and nitidine. Bioorg Med Chem (2006) 0.95
Sanguinarine-induced apoptosis is associated with an early and severe cellular glutathione depletion. Cancer Chemother Pharmacol (2003) 0.94
Prediction of survival in patients with thin melanoma: results from a multi-institution study. J Clin Oncol (2014) 0.93
Structure-activity relationships of diverse Annonaceous acetogenins against multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells. J Med Chem (1997) 0.92
Quality and safety issues of web-based information about herbal medicines in the treatment of cancer. Complement Ther Med (2004) 0.92
Consequences of using escharotic agents as primary treatment for nonmelanoma skin cancer. Arch Dermatol (2002) 0.91
Secondary intention healing: an alternative to surgical repair. Clin Dermatol (1986) 0.91
UV-A1 cytotoxicity and antioxidant defence in keratinocytes and fibroblasts. Eur J Dermatol (1999) 0.90
The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine. Cell Biol Toxicol (2006) 0.90
Escharotic agents, Fred Mohs, and Harry Hoxsey. J Am Acad Dermatol (2005) 0.89
The case for Mohs' surgery by the fixed-tissue technique. J Dermatol Surg Oncol (1981) 0.89
Sanguinarine interacts with chromatin, modulates epigenetic modifications, and transcription in the context of chromatin. Chem Biol (2009) 0.89
Natural occurring levels of dimethyl sulfoxide in selected fruits, vegetables, grains, and beverages. J Agric Food Chem (1982) 0.88
History of Mohs surgery. Dermatol Clin (2011) 0.87
Production of hydrogen peroxide and redox cycling can explain how sanguinarine and chelerythrine induce rapid apoptosis. Arch Biochem Biophys (2008) 0.87
Chemosurgery for the microscopically controlled excision of cutaneous cancer. Head Neck Surg (1979) 0.87
The benzophenanthridine alkaloid sanguinarine perturbs microtubule assembly dynamics through tubulin binding. A possible mechanism for its antiproliferative activity. FEBS J (2006) 0.87
Secondary intention healing after excision of nonmelanoma skin cancer of the head and neck: statistical evaluation of prognostic values of wound characteristics and final cosmetic results. Plast Reconstr Surg (2008) 0.86
Effects of sanguinarine and chelerythrine on the cell cycle and apoptosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2006) 0.86
The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. Mayo Clin Proc (2001) 0.86
Specific binding and self-structure induction to poly(A) by the cytotoxic plant alkaloid sanguinarine. Biochim Biophys Acta (2007) 0.86
Use of complementary medicine among outpatients with dermatologic conditions within Yorkshire and South Wales, United Kingdom. J Am Acad Dermatol (2005) 0.86
Elevational trends in defense chemistry, vegetation, and reproduction in Sanguinaria canadensis. J Chem Ecol (2001) 0.86
A review of topical corrosive black salve. J Altern Complement Med (2013) 0.84
Application of black salve to a thin melanoma that subsequently progressed to metastatic melanoma: a case study. Dermatol Pract Concept (2014) 0.84
Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up. Dermatology (2010) 0.84
Combined hinge flap full-thickness skin graft for a through-and-through nasal defect. Dermatol Surg (2008) 0.82
Healing by secondary intention. Dermatol Clin (1989) 0.80
Environmental and genotypic influences on isoquinoline alkaloid content in Sanguinaria canadensis. J Chem Ecol (2001) 0.79
Effect of quaternary benzo[c]phenanthridine alkaloids sanguilutine and chelilutine on normal and cancer cells. Toxicol In Vitro (2010) 0.79
Use of complementary and alternative medicine among adults with skin disease: results from a national survey. J Am Acad Dermatol (2009) 0.79
Binding of the anticancer alkaloid sanguinarine to double stranded RNAs: insights into the structural and energetics aspects. Mol Biosyst (2010) 0.78
Estimation of cardenolides in Nerium oleander. Planta Med (1973) 0.78
Clinical aspects of full-thickness wound healing. Clin Dermatol (2007) 0.78
Binding of the anticancer alkaloid sanguinarine with tRNA(phe): spectroscopic and calorimetric studies. J Biomol Struct Dyn (2012) 0.78
Auto-Mohs.com. Dermatol Surg (2001) 0.77
Fixed-tissue micrographic surgery in the treatment of cutaneous melanoma. An overlooked cancer treatment strategy. J Dermatol Surg Oncol (1992) 0.77
Accuracy of serial transverse cross-sections in detecting residual basal cell carcinoma at the surgical margins of an elliptical excision specimen. J Am Acad Dermatol (2005) 0.76
Multiple biological effects of inhibitors of arachidonic acid metabolism on human keratinocytes. Arch Dermatol Res (2002) 0.76
Histopathological features associated with application of black salve to cutaneous lesions: a series of 16 cases and review of the literature. Pathology (2013) 0.76
Deforming self-treatment with herbal "black salve". Dermatol Surg (2009) 0.76
Black salve as self-treatment for cutaneous squamous cell carcinoma. Dermatitis (2012) 0.76
Chemosurgery and skin cancer. AORN J (1971) 0.76
Chemosurgery for basal cell carcinoma. JAMA (1969) 0.76
Black salve and bloodroot extract in dermatologic conditions. Cutis (2015) 0.76
Clinical usefulness of Mohs' chemosurgery for palliative purposes in patients with cutaneous squamous cell carcinoma with risk factors or without indication for surgery: three case reports. J Dermatol (2015) 0.76
Use of unlicensed black salve for cutaneous malignancy. Med J Aust (2014) 0.76
Secondary healing after Mohs chemosurgery. Plast Reconstr Surg (1992) 0.76
Bloodroot associated eschar. Dermatol Online J (2014) 0.76
Zinc chloride paste for the debridement of chronic leg ulcers. J Dermatol Surg Oncol (1990) 0.76
Chemosurgical debridement of osteomyelitic bone by zinc chloride fixative. J Dermatol Surg Oncol (1987) 0.76
Histopathologic findings and diagnostic difficulties posed with use of escharotic agents for treatment of skin lesions: a case report and review of the literature. J Cutan Pathol (2008) 0.75
Sanguinaria canadensis: Traditional Medicine, Phytochemical Composition, Biological Activities and Current Uses. Int J Mol Sci (2016) 0.75
Zinc chloride inhibits human lens epithelial cell migration and proliferation involved in TGF-β1 and TNF-α signaling pathways in HLE B-3 cells. Biol Trace Elem Res (2014) 0.75
CHEMOSURGICAL AMPUTATION FOR GANGRENE. Surgery (1965) 0.75